It’s still early, but BMS-936558 is shaping up to be the ideal kind of cancer drug from a business standpoint. However, BMS-936558 will apparently have apparently plenty of competition, which speaks to the issue in #msg-76257542 and #msg-76302922.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.